4//SEC Filing
Urist Marshall 4
Accession 0001209191-23-010715
CIK 0001802768other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:57 PM ET
Size
9.3 KB
Accession
0001209191-23-010715
Insider Transaction Report
Form 4
Urist Marshall
EVP, Research & Investments
Transactions
- Conversion
LP interests in RPI US Partners 2019, LP
2023-02-17−7,000→ 128,594 totalExercise: $0.00→ Class A Ordinary Shares (70,000 underlying) - Conversion
Class A Ordinary Shares
2023-02-17+70,000→ 70,000 total
Holdings
- 19,020(indirect: By IRA)
Class A Ordinary Shares
Footnotes (3)
- [F1]These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.
- [F2]Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.
- [F3]The Reporting Person has agreed to retain and not sell 128,594 RPI US LP Interests convertible into 1,285,940 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001838139
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:57 PM ET
- Size
- 9.3 KB